Suicide is UK’s leading, and silent, cause of death for young people aged 20-34 years. Rona Strawbridge, UKRI Innovation, has used the population genomic data from the UK Biobank in an effort to find the genetic association of psychological condition phenotypes such as depression. She will be discussing her work at the upcoming Festival of Genomics. […]
Festival of Genomics
Dr Michelle Krishnan, Translational Medicine Leader in Rare Diseases at Roche, will by speaking at our upcoming Festival of Genomics. Her talk Clinical Development in Rare Diseases: Angelman Syndrome, From Disease Biology Insights to Genomic Medicine, will explain how to leverage disease biology insights to drive development of genomic medicines and discuss the cutting-edge clinical trial […]
The introduction of multi-omic research, the advancement of AI and machine learning to improve nearly every aspect of sequencing and data analysis, are just some of the big changes that will only become more prevalent in the future. We spoke to Angela Douglas MBE, Scientific Director of Genetics Laboratories at Liverpool Women’s Hospital, for her opinions on the changing nature of genomics and the trends to watch out for.
The Personal Genetics Education Project (pgEd) is an organisation which firmly believes in expanding genetics knowledge even further afield and increase awareness of the benefits and societal implications of personal genetics. We spoke to them about their goals, their concerns, and some of their biggest successes to date.
With so many talks and panels occurring across our four stages and Live Lounge, we understand that it can be pretty hard to pick out the most unmissable discussions at the festival this year. Given the conundrum, we thought we’d help out! We’ve selected a couple of talks and panels occurring across the two days which we think will be incredibly interesting and enormously informative for a whole range of people.
Front Line Genomics was created with a social mission after our founder lost his father to mesothelioma, a rare form of cancer commonly caused by exposure to asbestos. That’s why we thought it so important to showcase Nick Sireau, who co-founded the AKU Society to combat the disease, and is now about to finish a seven-year study into a drug which play a major part in eradicating AKU altogether.
With both our own festival and the wider life sciences sector moving rapidly towards a more integrative and holistic treatment of different -omics in research and drug development, we thought we’d get Dr. Dennis Wang, Lecturer in Bioinformatics and Genomics Medicine at the NIHR Sheffield Biomedical Research Centre, to talk us through the shift towards multi-omics.
Data integration has been one of the major trends of the last few years, and one which will become ever-more important as the life sciences sectors progress further. Dr. Maya Ghoussaini, Genetic Analysis Team Leader at the Wellcome Sanger Institute, and Dr. Denise Carvalho-Silva, Scientific Outreach Lead at EMBL-EBI, both working at Open Targets, here discuss the importance of this process, and their own work within the realm of data integration.
We know it’s hard to believe, but right now there are still some people who haven’t made up their minds to come to the 2019 Festival. Lucky for them we plan for every eventuality, and have prepared the five main reasons everyone should be registering their place at the event right now.
The Festival has really captured the imagination of leading scientists – particularly in the UK. So much so, that increasingly we are lucky to attract incredible speakers who hugely enrich the experience of our attendees. This year is stronger than ever. We luckily got a chance to visit some of our top speakers before the […]
With just under two weeks till the festival, it’s time to start thinking logistics. The more scatter-brained of our readers needn’t worry, however: we’ve got everything you need covered in this handy guide, whether it’s things to remember before you arrive at the festival, the best things to do once there and the last couple of things to remember when it’s all done.
There is a disconnect between scientists and the public when it comes to genomics. What is the public’s understanding of genomics and why is this important?
Dame Sally Davies insists that learning more about a patient’s genetic makeup will lead to a better and more cost-effective approach, that will ultimately spare resources in the system.